TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Biozone Scientific Scandinavia AB
Closing information (x1000 EUR)
| Closing information | 2023/12 | 2022/12 | 2021/12 |
| Turnover |
453
|
490
|
535 |
| Financial expenses |
1
|
3
|
2 |
| Earnings before taxes |
3
|
10
|
-7 |
| EBITDA |
2
|
12
|
-5 |
| Total assets |
98
|
154
|
198 |
| Current assets |
98
|
154
|
198 |
| Current liabilities |
33
|
68
|
86 |
| Equity capital |
65
|
86
|
112 |
| - share capital |
9
|
9
|
10 |
| Employees (average) |
2
|
2
|
2 |
Financial ratios
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Solvency |
66.3%
|
55.8%
|
56.6% |
| Turnover per employee |
226
|
245
|
268 |
| Profit as a percentage of turnover |
0.7%
|
2.0%
|
-1.3% |
| Return on assets (ROA) |
4.1%
|
8.4%
|
-2.5% |
| Current ratio |
297.0%
|
226.5%
|
230.2% |
| Return on equity (ROE) |
4.6%
|
11.6%
|
-6.2% |
| Change turnover |
-39
|
-2
|
-158 |
| Change turnover % |
-8%
|
0%
|
-23% |
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.